Laronde banks $440M to ramp up RNA-based meds that could turn cells into protein factories
Laronde launched out of Flagship Labs this year with a lofty vision: to deliver as many as 100 new RNA medicines over the next 10 years....
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page